Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

• Egile Nagusiak: C. Bazzani (Egilea), M. Frassi (Egilea), P. Airò (Egilea), S. Zingarelli (Egilea), M. Scarsi (Egilea), M. Puoti (Egilea)
• Formatua: Liburua
• Argitaratua: PAGEPress Publications, 2011-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Hepatitis B virus (HBV) is a DNA virus transmitted predominantly by sexual contact or percutaneous exposure. HBV infection is by far the most common chronic viral infection affecting the liver in the world, and a leading cause of cirrhosis and hepatocellular carcinoma. Reactivation of HBV replicatio...